Delivery Order SPE2DB20D1004-SPE2DB25FNEMC

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a diabetes treatment medication. The delivery order has a ceiling value of $3,003.00 and is a firm fixed price contract. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $3,642.95 and is a firm fixed-price delivery order. The contract has an ultimate completion date of May 9, 2025. This appears to be part of a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the U.S. The contract is for the supply of Trulicity 3 mg/0.5 ml pens, a medication used to manage diabetes. The contract has a ceiling value of $5,805.60 and is a firm-fixed price contract. It has an ultimate completion date of July 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pen, a medication used to treat diabetes. The contract has a ceiling value of $2,902.99 and a period of performance through April 29, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for Trulicity 1.5 mg/0.5 ml pens, a medication used for diabetes management. The contract has a ceiling value of $6,822.50 and a completion date of February 27, 2025. The contract is a firm fixed price delivery order, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract is a firm fixed-price delivery order with a ceiling value of $2,635.40 and a period of performance through April 23, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $3,018.48 and a period of performance through June 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,320.67, is for the delivery of Trulicity 1.5 mg/0.5 ml pens, a medication used to manage diabetes. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 3 mg/0.5 ml pens, a diabetes treatment medication. The contract has a firm fixed price, a ceiling value of $6,966.09, and a period of performance through April 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $4,043.08 and a period of performance through April 24, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB25FNEMC
    Delivery Order

This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 1.5 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a ceiling value of $3,003.00 and a term through January 27, 2025. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/27/25, 12:56 AM